FDA 483 - Consolidated Chemical, Inc - August 02, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Consolidated Chemical, Inc. DBA CARETECH Laboratories, Inc. in St. Louis, MO, a drug manufacturer, revealed significant deficiencies across multiple areas. Observations included inadequate procedures for preventing objectionable microorganisms, poor facility maintenance with leaks and exposed wiring, and corroded manufacturing equipment. Additionally, the firm failed to follow its written stability testing program and did not properly record or justify deviations from procedures.
ID · 052d3a19-8705-4518-a7c2-9a59700db542